Indeed, the mTOR pathway is constitutively activated in neurofibromin-deficient primary cells and tumours, and is regulated by phosphorylation and inactivation of the TSC2-encoded protein tuberin by AKT, ERK and RSK [13, 17]. This evidence concerns the gene MTOR and neoplasm.